Class II recall: American Regent, Inc.: Tralement (trace elements injection 4*, USP), packaged in a) 1mL Single Dose via
American Regent, Inc. is recalling Tralement (trace elements injection 4*, USP), packaged in 1mL single dose vials (NDC 0517-9305-01) and 5x1mL single dose vials (NDC 0517-9305-25), according to a Class II recall notice. The recall notice states the product was found to be contaminated with particulate matter identified as hair, glass, and/or paraformaldehyde.
Most relevant for: Patients receiving parenteral trace element supplementation who may have been administered contaminated Tralement injections from the affected lot numbers.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More oncology updates
- ASCO updates living guideline on advanced biliary tract cancer careOct 14, 2026
- Hypofractionated PMRT Noninferior to Conventional in Reconstruction PatientsOct 12, 2026
- Tomosynthesis screening shows lower interval cancer rate than mammographyOct 9, 2026
- Metastasis-directed ablation fails to improve PFS in oligometastatic breast cancer trialOct 7, 2026
- Updated pediatric guideline on antibacterial and antifungal prophylaxis in cancerOct 2, 2026